Abstract
The anemia associated with chronic renal failure is one of the best target diseases for erythropoietin (Epo) gene transfer. We previously reported a short-term (1 month) study of continuous rat Epo delivery by muscle-targeted gene transfer of plasmid DNA expressing rat Epo (pCAGGS-Epo) using in vivo electroporation in normal rats. Here, we performed a long-term pharmacokinetic study of continuous Epo delivery by this method in normal rats and uremic five-sixths nephrectomized rats. In normal rats, Epo gene expression and sufficient erythropoiesis occurred with Epo gene transfer in a dose-dependent manner, and persisted for at least 11 weeks. Repeated administration of the plasmid DNA effectively produced erythropoiesis. Similar erythropoiesis was observed in the uremic rats, and persisted for more than 15 weeks. Both normal and uremic rats showed a significant decrease in platelet count. Moreover, the uremic rats showed Epo-induced hypertension, which is the major side-effect of recombinant human Epo. These results demonstrate that muscle-targeted pCAGGS-Epo transfer by in vivo electroporation is a useful procedure for the long-term continuous delivery of Epo in both normal and uremic rats.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Koury MJ, Bondurant MC . Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells Science 1990 248: 378–381
Ledkey FD . Nonviral gene therapy: the promise of genes as pharmaceutical products Hum Gene Ther 1995 6: 1129–1144
Wolff JA et al. Direct gene transfer into mouse muscle in vivo Science 1990 247: 1465–1468
Wolff JA et al. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle Hum Mol Genet 1992 1: 363–369
Aihara H, Miyazaki J . Gene transfer into muscle by electroporation in vivo Nature Biotechnol 1998 16: 867–870
Maruyama H et al. Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation Hum Gene Ther 2000 11: 429–437
Winearls CG et al. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis Lancet 1986 2: 1175–1178
Eschbach JW et al. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin N Engl J Med 1987 316: 73–78
Roth D et al. Effects of recombinant human erythropoietin on renal function in chronic renal failure in predialysis patients Am J Kidney Dis 1994 24: 777–784
Garcia DL, Anderson S, Rennke HG, Brenner BM . Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass Proc Natl Acad Sci USA 1988 85: 142–146
Hamamori Y, Samal B, Tian J, Kedes L . Myoblast transfer of human erythropoietin gene in a mouse model of renal failure J Clin Invest 1995 95: 1808–1813
Osada S et al. Gene therapy for renal anemia in mice with polycystic kidney using an adenovirus encoding the human erythropoietin gene Kidney Int 1999 55: 1234–1240
Maione D et al. Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vector Hum Gene Ther 2000 11: 859–868
Osborne WRA et al. Gene therapy for long-term expression of erythropoietin in rats Proc Natl Acad Sci USA 1995 92: 8055–8058
Tripathy SK et al. Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector Proc Natl Acad Sci USA 1996 93: 10876–10880
Rizzuto G et al. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation Proc Natl Acad Sci USA 1999 96: 6417–6422
Boel D, Heard J-M . Modulation of erythropoietin delivery from engineered muscles in mice Hum Gene Ther 1997 8: 195–204
Klinman DM et al. Safe and effective regulation of hematocrit by gene gun administration of an erythropoietin-encoding DNA plasmid Hum Gene Ther 1999 10: 659–665
Wells DJ, Goldspink G . Age and sex influence expression of plasmid DNA directly injected into mouse skeletal muscle FEBS Lett 1992 306: 203–205
Japanese Society for Dialysis Therapy . An overview of dialysis treatment in Japan (as of 31 Dec 1998) J Jpn Soc Dial Ther 2000 33: 1–27
Vicat JM et al. Muscle transfection by electroporation with high-voltage and short-pulse currents provides high-level and long-lasting gene expression Hum Gene Ther 2000 11: 909–916
McDonald TP, Clift R, Cottrell MB . Large, chronic doses of erythropoietin cause thrombocytopenia in mice Blood 1992 80: 352–358
Markham A, Bryson HM . Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications Drugs 1995 49: 232–254
Berglund B, Ekblom B . Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men J Intern Med 1991 229: 125–130
Poux JM et al. Uraemia is necessary for erythropoietin-induced hypertension in rats Clin Exp Pharmacol Physiol 1995 22: 769–771
Lacasse-M S et al. Uremia enhances the blood pressure response to erythropoietin Clin Exp Hypertens 1997 19: 389–401
Hörl WH . Genetics of the uraemic syndrome. In: Davison AM et al (eds) Oxford Textbook of Clinical Nephrology Oxford University Press: Oxford 1998 1821–1836
Niwa H, Yamamura K, Miyazaki J . Efficient selection for high-expression transfectants with a novel eukaryotic vector Gene 1991 108: 193–199
Anagnostou A, Vercellotti G, Barone J, Fried W . Factors which affect erythropoiesis in partially nephrectomized and sham-operated rats Blood 1976 48: 425–433
Ohwada K . Improvement of cardiac puncture in mice Exp Anim 1986 35: 353–355 (Japanese)
Kuwahara M et al. Evaluation of a new tail-cuff method for blood pressure measurement in rats with special reference to the effects of ambient temperature Exp Anim 1991 40: 331–336
Beru N, McDonald J, Lacombe C, Goldwasser E . Expression of the erythropoietin gene Mol Cell Biol 1986 6: 2571–2575
Bondurant MC, Koury MJ . Anemia induces accumulation of erythropoietin mRNA in the kidney and liver Mol Cell Biol 1986 6: 2731–2733
Acknowledgements
This work was partly supported by a grant to H Maruyama and M Sugawa from the Renal Anemia Foundation (Tokyo). The authors are grateful to K Yamagiwa of the Department of Medicine II, and Y Maeda and Y Yamamoto of the Institute for Laboratory Animals, Niigata University School of Medicine, for technical assistance.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maruyama, H., Ataka, K., Gejyo, F. et al. Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats. Gene Ther 8, 461–468 (2001). https://doi.org/10.1038/sj.gt.3301412
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301412
Keywords
This article is cited by
-
Induction of a local muscular dystrophy using electroporation in vivo: an easy tool for screening therapeutics
Scientific Reports (2020)
-
Minimal doses of a sequence-optimized transgene mediate high-level and long-term EPO expression in vivo: challenging CpG-free gene design
Gene Therapy (2011)
-
Careful adjustment of Epo non-viral gene therapy for β-thalassemic anaemia treatment
Genetic Vaccines and Therapy (2008)
-
Sensitive and precise regulation of haemoglobin after gene transfer of erythropoietin to muscle tissue using electroporation
Gene Therapy (2007)
-
Gene therapy targeting kidney diseases: routes and vehicles
Clinical and Experimental Nephrology (2006)